Despite the endless emergence of drugs targeting S100A8/A9 and its receptors, which substantially inhibit different characteristics of tumor cells, they are only at the level of theoretical research, regrettably, there are no drugs that can be applied in practical life. Here, S100A8 is linked to neoplasm.